Clinical Trial Update: Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating high-intensity focused ultrasound (HIFU) with or without PD-1 inhibitors, followed by Abraxane (nab-paclitaxel) plus carb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)
• PD-1 inhibitors

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Triple Negative Breast Cancer (TNBC) | Phase 2 | Status: RECRUITING